Taro Pharmaceutical Industries Net Profit Margin 2006-2020 | TARO

Taro Pharmaceutical Industries net profit margin from 2006 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue.
Taro Pharmaceutical Industries Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2020-06-30 $0.60B $-0.26B -42.69%
2020-03-31 $0.65B $0.24B 37.83%
2019-12-31 $0.65B $0.25B 38.15%
2019-09-30 $0.68B $0.27B 40.41%
2019-06-30 $0.68B $0.28B 41.57%
2019-03-31 $0.67B $0.28B 42.09%
2018-12-31 $0.67B $0.31B 46.62%
2018-09-30 $0.64B $0.23B 36.34%
2018-06-30 $0.66B $0.22B 34.05%
2018-03-31 $0.66B $0.21B 31.77%
2017-12-31 $0.68B $0.21B 30.35%
2017-09-30 $0.75B $0.33B 44.04%
2017-06-30 $0.81B $0.40B 49.75%
2017-03-31 $0.88B $0.46B 51.99%
2016-12-31 $0.95B $0.49B 51.58%
2016-09-30 $0.99B $0.54B 54.56%
2016-06-30 $0.97B $0.55B 56.45%
2016-03-31 $0.95B $0.54B 56.95%
2015-12-31 $0.93B $0.58B 62.22%
2015-09-30 $0.91B $0.53B 58.42%
2015-06-30 $0.95B $0.54B 57.07%
2015-03-31 $0.86B $0.48B 55.97%
2014-12-31 $0.81B $0.42B 52.23%
2014-09-30 $0.78B $0.40B 50.51%
2014-06-30 $0.74B $0.35B 47.28%
2014-03-31 $0.76B $0.36B 47.56%
2013-12-31 $0.74B $0.32B 43.42%
2013-09-30 $0.71B $0.29B 41.33%
2013-06-30 $0.67B $0.26B 39.40%
2013-03-31 $0.67B $0.27B 39.64%
2012-12-31 $0.65B $0.26B 40.55%
2012-09-30 $0.61B $0.24B 38.66%
2012-06-30 $0.59B $0.23B 39.15%
2012-03-31 $0.54B $0.20B 37.57%
2011-12-31 $0.51B $0.18B 36.17%
2011-09-30 $0.46B $0.13B 27.17%
2011-06-30 $0.43B $0.09B 20.00%
2011-03-31 $0.41B $0.07B 16.55%
2010-12-31 $0.39B $0.05B 13.27%
2010-09-30 $0.38B $0.06B 15.73%
2010-06-30 $0.37B $0.05B 13.66%
2010-03-31 $0.37B $0.04B 11.78%
2009-09-30 $0.28B $0.04B 14.49%
2009-06-30 $0.27B $0.04B 15.81%
2008-09-30 $0.17B $0.02B 10.65%
2006-03-31 $0.30B $0.01B 1.67%
2005-12-31 $0.30B $0.01B 1.67%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.097B $0.645B
Taro Pharmaceutical Industries is engaged in the production, research and development, and marketing of prescription and over-the-counter pharmaceutical products, with a focus on generic products. In addition to the production of finished dosage form drugs, they also synthesize the pharmaceutical chemicals used in their production. Products are sold through wholesalers, generic drug distributors, drug store chains, mass merchandisers, HMOs, food stores, pharmacies and hospitals.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.422B 43.47
Takeda Pharmaceutical (TAK) Japan $58.420B 10.18
Astellas Pharma (ALPMY) Japan $28.504B 0.00
Eisai (ESALY) Japan $26.706B 22.57
UCB SA (UCBJF) Belgium $22.660B 0.00
Merck (MKGAF) Germany $18.456B 0.00
Ono Pharmaceutical (OPHLF) Japan $15.737B 27.83
Catalent (CTLT) United States $13.487B 43.84
Grifols, S.A (GRFS) Spain $11.393B 13.92
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $9.111B 35.27
IPSEN SA ADR (IPSEY) France $8.650B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.360B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.741B 12.81
STADA ARZNEIMI (STDAF) Germany $7.169B 0.00
Orion OYJ (ORINY) Finland $7.077B 24.56
Ionis Pharmaceuticals (IONS) United States $6.803B 43.10
Arrowhead Pharmaceuticals (ARWR) United States $4.594B 0.00
United Therapeutics (UTHR) United States $4.461B 10.31
Evotec AG (EVTCY) Germany $4.033B 140.00
FibroGen (FGEN) United States $3.819B 0.00
ChemoCentryx (CCXI) United States $3.633B 0.00
Hypermarcas (HYPMY) Brazil $3.496B 12.86
Sage Therapeutics (SAGE) United States $3.161B 0.00
PTC Therapeutics (PTCT) United States $3.155B 0.00
Nektar Therapeutics (NKTR) United States $3.150B 0.00
Pacira BioSciences (PCRX) United States $2.518B 66.19
Revolution Medicines (RVMD) United States $2.167B 0.00
Xencor (XNCR) United States $2.161B 0.00
Corcept Therapeutics (CORT) United States $1.975B 18.18
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.799B 0.00
Cronos Group (CRON) Canada $1.777B 0.00
USANA Health Sciences (USNA) United States $1.571B 14.80
Ironwood Pharmaceuticals (IRWD) United States $1.512B 10.50
Trillium Therapeutics (TRIL) Canada $1.345B 0.00
Heron Therapeutics (HRTX) United States $1.327B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.187B 11.31
Indivior (INVVY) United States $1.162B 14.40
Karyopharm Therapeutics (KPTI) United States $1.090B 0.00
Esperion Therapeutics (ESPR) United States $1.044B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.005B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.991B 0.00
Translate Bio (TBIO) United States $0.975B 0.00
Zogenix (ZGNX) United States $0.970B 0.00
Vectura Group (VEGPF) United Kingdom $0.894B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.877B 546.13
VAXART, INC (VXRT) United States $0.808B 0.00
Endo (ENDP) Ireland $0.753B 1.11
BioCryst Pharmaceuticals (BCRX) United States $0.643B 0.00
ImmunoGen (IMGN) United States $0.642B 0.00
Collegium Pharmaceutical (COLL) United States $0.638B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.627B 0.00
Tilray (TLRY) Canada $0.609B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.561B 0.00
Siga Technologies (SIGA) United States $0.550B 58.67
Flexion Therapeutics (FLXN) United States $0.543B 0.00
Molecular Templates (MTEM) United States $0.523B 0.00
Aerie Pharmaceuticals (AERI) United States $0.521B 0.00
Radius Health (RDUS) United States $0.509B 0.00
Ocular Therapeutix (OCUL) United States $0.497B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.484B 0.00
Ardelyx (ARDX) United States $0.480B 0.00
Altimmune (ALT) United States $0.425B 0.00
Organogenesis Holdings (ORGO) United States $0.396B 0.00
Harpoon Therapeutics (HARP) United States $0.389B 0.00
TherapeuticsMD (TXMD) United States $0.384B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.383B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.382B 19.03
Redhill Biopharma (RDHL) Israel $0.356B 0.00
Akebia Therapeutics (AKBA) United States $0.355B 0.00
DURECT (DRRX) United States $0.355B 0.00
MEI Pharma (MEIP) United States $0.351B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.327B 8.10
Innate Pharma SA (IPHYF) France $0.324B 0.00
PROFOUND MEDICL (PROF) Canada $0.324B 0.00
IMV INC (IMV) Canada $0.295B 0.00
Jounce Therapeutics (JNCE) United States $0.280B 13.27
Xeris Pharmaceuticals (XERS) United States $0.266B 0.00
Concert Pharmaceuticals (CNCE) United States $0.265B 0.00
Aquestive Therapeutics (AQST) United States $0.256B 0.00
Menlo Therapeutics (VYNE) United States $0.255B 0.00
Rafael Holdings (RFL) United States $0.255B 0.00
Calithera Biosciences (CALA) United States $0.237B 0.00
Lannett Co Inc (LCI) United States $0.236B 5.48
KalVista Pharmaceuticals (KALV) United States $0.231B 0.00
Nature's Sunshine Products (NATR) United States $0.218B 21.50
Avadel Pharmaceuticals (AVDL) Ireland $0.196B 0.00
Nivalis Therapeutics (ALPN) United States $0.195B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.194B 0.00
Heat Biologics (HTBX) United States $0.190B 0.00
CASI Pharmaceuticals (CASI) United States $0.188B 0.00
Otonomy (OTIC) United States $0.174B 0.00
OptiNose (OPTN) United States $0.172B 0.00
Taiwan Liposome (TLC) Taiwan $0.170B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.164B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.140B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.135B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.128B 0.00
Champions Oncology (CSBR) United States $0.119B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.110B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.107B 0.00
Aclaris Therapeutics (ACRS) United States $0.105B 0.00
MediWound (MDWD) Israel $0.101B 0.00
Lipocine (LPCN) United States $0.093B 0.00
Biomerica (BMRA) United States $0.083B 0.00
CTI BioPharma (CTIC) United States $0.077B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.076B 0.00
ElectroCore (ECOR) United States $0.072B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.071B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.071B 0.00
Novan (NOVN) United States $0.069B 0.00
Addex Therapeutics (ADXN) Switzerland $0.068B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.064B 0.00
Infinity Pharmaceuticals (INFI) United States $0.063B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.063B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.053B 0.00
Onconova Therapeutics (ONTX) United States $0.052B 0.00
KemPharm (KMPH) United States $0.051B 0.00
Natural Alternatives (NAII) United States $0.050B 0.00
CV Sciences (CVSI) United States $0.050B 0.00
Recro Pharma (REPH) United States $0.049B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 29.36
SCYNEXIS (SCYX) United States $0.048B 0.00
ProPhase Labs (PRPH) United States $0.044B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
PolarityTE (PTE) United States $0.040B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.038B 0.00
GTx (ONCT) United States $0.036B 0.00
Mannatechorporated (MTEX) United States $0.035B 8.96
Opiant Pharmaceuticals (OPNT) United States $0.033B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.033B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.030B 0.00
Neos Therapeutics (NEOS) United States $0.028B 0.00
Jaguar Animal Health (JAGX) United States $0.025B 0.00
Vical (BBI) United States $0.023B 0.00
Midatech Pharma (MTP) United Kingdom $0.022B 0.00
Sundial Growers (SNDL) Canada $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
HANCOCK JAFFE (HJLI) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.016B 23.36
Bio-Path Holdings (BPTH) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
China SXT Pharmaceuticals (SXTC) China $0.009B 0.00
Shineco (TYHT) China $0.009B 0.00
JanOne (JAN) United States $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00